| glycerolipid metabolic process | GO:0046486 | 122 | 0.979 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.977 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.966 | |
| triglyceride catabolic process | GO:0019433 | 9 | 0.956 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.945 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.939 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.931 | |
| positive regulation of lipoprotein lipase activity | GO:0051006 | 3 | 0.914 | |
| acylglycerol catabolic process | GO:0046464 | 11 | 0.905 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.902 | |
| positive regulation of triglyceride catabolic process | GO:0010898 | 3 | 0.888 | |
| sterol metabolic process | GO:0016125 | 58 | 0.884 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.859 | |
| positive regulation of triglyceride lipase activity | GO:0061365 | 3 | 0.832 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.832 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.779 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.760 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.722 | |
| neutral lipid catabolic process | GO:0046461 | 11 | 0.673 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.641 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.627 | |
| positive regulation of lipid catabolic process | GO:0050996 | 6 | 0.604 | |
| lipid catabolic process | GO:0016042 | 69 | 0.604 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.595 | |
| sequestering of triglyceride | GO:0030730 | 6 | 0.575 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.563 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.553 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.511 | |
| regulation of triglyceride catabolic process | GO:0010896 | 5 | 0.486 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.454 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.451 | |
| regulation of fatty acid oxidation | GO:0046320 | 10 | 0.394 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.346 | |
| response to ischemia | GO:0002931 | 14 | 0.333 | |
| vacuole organization | GO:0007033 | 38 | 0.331 | |
| negative regulation of lipid catabolic process | GO:0050995 | 6 | 0.310 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.301 | |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 1 | 0.295 | |
| sterol transmembrane transport | GO:0035382 | 2 | 0.294 | |
| regulation of sequestering of triglyceride | GO:0010889 | 6 | 0.290 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.286 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 0.284 | |
| lipid localization | GO:0010876 | 126 | 0.283 | Worm |
| positive regulation of fatty acid oxidation | GO:0046321 | 4 | 0.280 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.276 | |
| sterol transport | GO:0015918 | 38 | 0.273 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.266 | |
| lipid homeostasis | GO:0055088 | 63 | 0.259 | |
| amine metabolic process | GO:0009308 | 45 | 0.252 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.243 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.240 | |
| lipid storage | GO:0019915 | 36 | 0.235 | Worm |
| cholesterol homeostasis | GO:0042632 | 44 | 0.231 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.226 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.212 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.212 | |
| steroid metabolic process | GO:0008202 | 119 | 0.210 | |
| cholesterol storage | GO:0010878 | 4 | 0.208 | |
| sterol homeostasis | GO:0055092 | 45 | 0.208 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.205 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.205 | |
| autophagy | GO:0006914 | 45 | 0.196 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.187 | |
| phospholipid catabolic process | GO:0009395 | 5 | 0.185 | |
| protein localization to organelle | GO:0033365 | 185 | 0.176 | Worm |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.175 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.174 | |
| microtubule based process | GO:0007017 | 236 | 0.169 | Worm |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.165 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.156 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.155 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.153 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.151 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.151 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.141 | |
| single organism nuclear import | GO:1902593 | 95 | 0.139 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.138 | |
| lipid particle organization | GO:0034389 | 7 | 0.133 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.132 | |
| protein catabolic process | GO:0030163 | 221 | 0.128 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.127 | |
| microtubule based movement | GO:0007018 | 84 | 0.121 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.120 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.120 | |
| dna metabolic process | GO:0006259 | 303 | 0.119 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.118 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.114 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.112 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.111 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.110 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.109 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.108 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.108 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.107 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.106 | |
| oxidation reduction process | GO:0055114 | 342 | 0.105 | |
| mapk cascade | GO:0000165 | 281 | 0.102 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.100 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.099 | |
| cellular response to increased oxygen levels | GO:0036295 | 1 | 0.097 | |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.091 | |
| cholesterol transport | GO:0030301 | 38 | 0.091 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.091 | |
| cellular response to peptide | GO:1901653 | 92 | 0.091 | |
| intestinal absorption | GO:0050892 | 13 | 0.088 | |
| response to peptide hormone | GO:0043434 | 127 | 0.088 | |
| response to nutrient levels | GO:0031667 | 109 | 0.084 | |
| fat cell differentiation | GO:0045444 | 160 | 0.084 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.083 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.082 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.081 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.081 | |
| cholesterol esterification | GO:0034435 | 3 | 0.081 | |
| lipid transport | GO:0006869 | 98 | 0.080 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.080 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.079 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.078 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.078 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.077 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.076 | |
| epidermis development | GO:0008544 | 187 | 0.075 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.075 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.074 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.073 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.072 | |
| cofactor metabolic process | GO:0051186 | 80 | 0.072 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.071 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.070 | |
| hexose metabolic process | GO:0019318 | 98 | 0.069 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.069 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.068 | |
| cellular response to starvation | GO:0009267 | 57 | 0.067 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.067 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.066 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.065 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.065 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.065 | |
| cholesterol import | GO:0070508 | 2 | 0.064 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.063 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.062 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.062 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.062 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.061 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.059 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.059 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.059 | |
| regulation of mitochondrial fission | GO:0090140 | 3 | 0.058 | |
| valine metabolic process | GO:0006573 | 4 | 0.058 | |
| steroid esterification | GO:0034433 | 3 | 0.058 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.057 | |
| circadian rhythm | GO:0007623 | 114 | 0.057 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.057 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.056 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.056 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.056 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.056 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.056 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.056 | |
| appendage development | GO:0048736 | 166 | 0.055 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.055 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.055 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.054 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.054 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.054 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.054 | |
| negative regulation of lipid storage | GO:0010888 | 6 | 0.053 | |
| negative regulation of sequestering of triglyceride | GO:0010891 | 2 | 0.053 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.053 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.053 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.053 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.052 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.052 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.052 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.051 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.051 | |
| regulation of p38mapk cascade | GO:1900744 | 3 | 0.050 | |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.050 | |
| response to starvation | GO:0042594 | 65 | 0.049 | |
| glucose homeostasis | GO:0042593 | 128 | 0.049 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.049 | |
| lipid oxidation | GO:0034440 | 29 | 0.049 | |
| endocytosis | GO:0006897 | 168 | 0.048 | |
| mitochondrion organization | GO:0007005 | 134 | 0.048 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.047 | |
| membrane organization | GO:0061024 | 245 | 0.047 | Worm |
| reverse cholesterol transport | GO:0043691 | 6 | 0.047 | |
| maintenance of location | GO:0051235 | 89 | 0.047 | Worm |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.047 | |
| p38mapk cascade | GO:0038066 | 4 | 0.046 | |
| regulation of phospholipid catabolic process | GO:0060696 | 2 | 0.046 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.046 | |
| nuclear transport | GO:0051169 | 139 | 0.046 | |
| organic acid catabolic process | GO:0016054 | 51 | 0.046 | |
| sterol esterification | GO:0034434 | 3 | 0.046 | |
| cellular homeostasis | GO:0019725 | 240 | 0.046 | |
| chromatin modification | GO:0016568 | 187 | 0.046 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.045 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.045 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.045 | |
| regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000161 | 1 | 0.045 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.044 | |
| protein glycosylation | GO:0006486 | 55 | 0.044 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.043 | |
| response to hyperoxia | GO:0055093 | 2 | 0.043 | |
| coenzyme metabolic process | GO:0006732 | 52 | 0.043 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.043 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.043 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.042 | |
| cellular response to prostaglandin stimulus | GO:0071379 | 2 | 0.042 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.042 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.042 | |
| male gamete generation | GO:0048232 | 285 | 0.041 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.041 | |
| intracellular protein transport | GO:0006886 | 204 | 0.041 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.041 | |
| locomotory behavior | GO:0007626 | 195 | 0.040 | |
| negative regulation of reactive oxygen species biosynthetic process | GO:1903427 | 0 | 0.040 | |
| cell proliferation in hindbrain | GO:0021534 | 10 | 0.039 | |
| cell maturation | GO:0048469 | 127 | 0.039 | |
| endomembrane system organization | GO:0010256 | 147 | 0.038 | Worm |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.038 | |
| glycerophospholipid catabolic process | GO:0046475 | 5 | 0.038 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.038 | |
| thioester biosynthetic process | GO:0035384 | 7 | 0.038 | |
| glycosylation | GO:0070085 | 62 | 0.037 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.037 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.037 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.037 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.037 | |
| gland development | GO:0048732 | 330 | 0.037 | |
| limb morphogenesis | GO:0035108 | 149 | 0.037 | |
| regulation of presynaptic membrane organization | GO:1901629 | 3 | 0.037 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.036 | |
| high density lipoprotein particle remodeling | GO:0034375 | 4 | 0.036 | |
| fatty acid beta oxidation | GO:0006635 | 16 | 0.036 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.036 | |
| muscle adaptation | GO:0043500 | 39 | 0.036 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.036 | |
| immune effector process | GO:0002252 | 321 | 0.036 | |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.036 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.036 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.036 | |
| adiponectin activated signaling pathway | GO:0033211 | 4 | 0.036 | |
| muscle tissue development | GO:0060537 | 308 | 0.035 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.035 | |
| hormone secretion | GO:0046879 | 128 | 0.035 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.035 | |
| cellular amino acid catabolic process | GO:0009063 | 25 | 0.035 | |
| negative regulation of tyrosine phosphorylation of stat5 protein | GO:0042524 | 2 | 0.035 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.035 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.035 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.035 | |
| negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000162 | 1 | 0.034 | |
| glucose import | GO:0046323 | 32 | 0.034 | |
| synaptic transmission | GO:0007268 | 329 | 0.033 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.033 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.033 | |
| vitamin d biosynthetic process | GO:0042368 | 3 | 0.033 | |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.033 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.033 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.033 | |
| nuclear division | GO:0000280 | 158 | 0.033 | Worm |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.033 | |
| thioester metabolic process | GO:0035383 | 19 | 0.033 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.033 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.033 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.032 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.032 | |
| protein ubiquitination | GO:0016567 | 171 | 0.032 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.032 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.032 | |
| telencephalon development | GO:0021537 | 186 | 0.032 | |
| acetyl coa biosynthetic process | GO:0006085 | 5 | 0.032 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.032 | |
| monocarboxylic acid catabolic process | GO:0072329 | 27 | 0.031 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.031 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.031 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.031 | |
| ossification | GO:0001503 | 216 | 0.031 | |
| regulation of cholesterol homeostasis | GO:2000188 | 9 | 0.031 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.031 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.031 | |
| negative regulation of map kinase activity | GO:0043407 | 34 | 0.030 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.030 | |
| spermatogenesis | GO:0007283 | 284 | 0.030 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.030 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.030 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.029 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.029 | |
| fatty acid oxidation | GO:0019395 | 28 | 0.029 | |
| sensory perception of umami taste | GO:0050917 | 4 | 0.029 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.029 | |
| positive regulation of presynaptic membrane organization | GO:1901631 | 1 | 0.029 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.029 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.029 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.028 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.028 | |
| circadian regulation of gene expression | GO:0032922 | 48 | 0.028 | |
| lateral line system development | GO:0048925 | 1 | 0.028 | |
| protein import | GO:0017038 | 101 | 0.028 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.028 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.028 | |
| protein localization to membrane | GO:0072657 | 108 | 0.028 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.028 | |
| nuclear import | GO:0051170 | 95 | 0.028 | |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.028 | |
| response to metal ion | GO:0010038 | 47 | 0.027 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.027 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.027 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.027 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.027 | |
| negative regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000587 | 2 | 0.027 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.027 | |
| keratinocyte migration | GO:0051546 | 3 | 0.027 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.027 | |
| coenzyme biosynthetic process | GO:0009108 | 23 | 0.027 | |
| intracellular lipid transport | GO:0032365 | 3 | 0.027 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.027 | |
| cellular respiration | GO:0045333 | 38 | 0.026 | |
| amide transport | GO:0042886 | 138 | 0.026 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.026 | |
| regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000163 | 1 | 0.026 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.026 | |
| response to epidermal growth factor | GO:0070849 | 4 | 0.026 | |
| positive regulation of metalloenzyme activity | GO:0048554 | 3 | 0.026 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.026 | |
| organelle localization | GO:0051640 | 179 | 0.026 | |
| lipid modification | GO:0030258 | 65 | 0.026 | |
| transmembrane transport | GO:0055085 | 412 | 0.026 | |
| limb development | GO:0060173 | 166 | 0.026 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.026 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.026 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.025 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.025 | |
| response to oxygen levels | GO:0070482 | 62 | 0.025 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.025 | |
| sterol import | GO:0035376 | 2 | 0.025 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.025 | Worm |
| macromolecule glycosylation | GO:0043413 | 55 | 0.025 | |
| cytokine production | GO:0001816 | 319 | 0.025 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.025 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.025 | |
| regulation of cell activation | GO:0050865 | 289 | 0.025 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.025 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.025 | |
| organelle fission | GO:0048285 | 170 | 0.025 | |
| glucose metabolic process | GO:0006006 | 92 | 0.025 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.025 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.024 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.024 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.024 | |
| neuron death | GO:0070997 | 154 | 0.024 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.024 | |
| hormone mediated signaling pathway | GO:0009755 | 23 | 0.024 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.024 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.024 | |
| response to copper ion | GO:0046688 | 3 | 0.024 | |
| defense response to other organism | GO:0098542 | 197 | 0.024 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.024 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.024 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.024 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.024 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.024 | |
| protein targeting | GO:0006605 | 143 | 0.024 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.023 | |
| cellular response to arsenic containing substance | GO:0071243 | 4 | 0.023 | |
| gluconeogenesis | GO:0006094 | 39 | 0.023 | |
| positive regulation of bone remodeling | GO:0046852 | 13 | 0.023 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.023 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.023 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.023 | |
| bone morphogenesis | GO:0060349 | 78 | 0.023 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.023 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.023 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.023 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.023 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.023 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.023 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.022 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.022 | |
| receptor mediated endocytosis of low density lipoprotein particle involved in cholesterol transport | GO:0090118 | 1 | 0.022 | |
| organic anion transport | GO:0015711 | 137 | 0.022 | |
| response to growth factor | GO:0070848 | 198 | 0.022 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.022 | |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.022 | |
| response to monosaccharide | GO:0034284 | 67 | 0.022 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.022 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.022 | Worm |
| response to steroid hormone | GO:0048545 | 56 | 0.022 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.022 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.022 | |
| heart morphogenesis | GO:0003007 | 178 | 0.022 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | |
| alcohol catabolic process | GO:0046164 | 16 | 0.021 | |
| gas homeostasis | GO:0033483 | 3 | 0.021 | |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.021 | |
| hair follicle development | GO:0001942 | 85 | 0.021 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.021 | |
| bone development | GO:0060348 | 120 | 0.021 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.021 | |
| fatty acid catabolic process | GO:0009062 | 25 | 0.021 | |
| camera type eye development | GO:0043010 | 266 | 0.021 | |
| regulation of pinocytosis | GO:0048548 | 1 | 0.021 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.021 | |
| notochord cell development | GO:0060035 | 1 | 0.021 | |
| regulation of fatty acid beta oxidation | GO:0031998 | 1 | 0.021 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.021 | |
| glucan biosynthetic process | GO:0009250 | 14 | 0.021 | |
| regionalization | GO:0003002 | 337 | 0.021 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.021 | |
| urogenital system development | GO:0001655 | 261 | 0.020 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.020 | |
| cell fate commitment | GO:0045165 | 210 | 0.020 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.020 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.020 | |
| positive regulation of proteolysis involved in cellular protein catabolic process | GO:1903052 | 31 | 0.020 | |
| digestive tract development | GO:0048565 | 190 | 0.020 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.020 | |
| negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000164 | 1 | 0.020 | |
| negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000149 | 1 | 0.020 | |
| membrane raft assembly | GO:0001765 | 3 | 0.020 | |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.020 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.020 | |
| developmental maturation | GO:0021700 | 193 | 0.020 | |
| macromolecular complex remodeling | GO:0034367 | 6 | 0.020 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.020 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.020 | |
| protein maturation | GO:0051604 | 176 | 0.020 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.020 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.020 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.020 | |
| establishment of mitochondrion localization | GO:0051654 | 4 | 0.020 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.020 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.020 | |
| body fluid secretion | GO:0007589 | 53 | 0.020 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.020 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.020 | |
| regulation of intestinal cholesterol absorption | GO:0030300 | 4 | 0.020 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.020 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.020 | |
| neural tube development | GO:0021915 | 160 | 0.019 | |
| negative regulation of neuron projection development | GO:0010977 | 50 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.019 | |
| response to vitamin a | GO:0033189 | 1 | 0.019 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.019 | |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.019 | |
| cerebellar granule cell precursor proliferation | GO:0021930 | 10 | 0.019 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.019 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.019 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.019 | |
| alcohol biosynthetic process | GO:0046165 | 43 | 0.019 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.019 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.019 | |
| regulation of ion transport | GO:0043269 | 215 | 0.019 | |
| sensory system development | GO:0048880 | 3 | 0.019 | |
| action potential | GO:0001508 | 78 | 0.019 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.019 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.019 | |
| positive regulation of steroid biosynthetic process | GO:0010893 | 4 | 0.019 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.019 | |
| response to acid chemical | GO:0001101 | 111 | 0.019 | |
| response to oxygen radical | GO:0000305 | 16 | 0.019 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.019 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.019 | |
| organophosphate ester transport | GO:0015748 | 28 | 0.019 | |
| lipoprotein transport | GO:0042953 | 7 | 0.019 | |
| inclusion body assembly | GO:0070841 | 3 | 0.018 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.018 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.018 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.018 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.018 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.018 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.018 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.018 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.018 | |
| multicellular organism growth | GO:0035264 | 161 | 0.018 | Worm |
| protein processing | GO:0016485 | 163 | 0.018 | |
| positive regulation of sequestering of triglyceride | GO:0010890 | 4 | 0.018 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.018 | |
| positive regulation of transcription from rna polymerase ii promoter in response to acidic ph | GO:0061402 | 2 | 0.018 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.018 | |
